Press Releases

Date	Title	Company
23-Feb-2023	Genmab Publishes 2022 Annual Report	Genmab
23-Feb-2023	EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific	EVERSANA CONSULTING
23-Feb-2023	The dug of abuse testing market is expected to expand at a 5.19% CAGR over the forecast to 2031	MARKITWIRED
23-Feb-2023	Dermal Fillers Market is projected to grow from US$ 5.2 Bn in 2022 to US$ 6.72 Bn by 2031	MARKITWIRED
23-Feb-2023	Demand for Starter Cultures, in terms of Value, is projected to Cross US$ 2 billion by 2033	MARKITWIRED
23-Feb-2023	Increasing Incidence of Whim Syndrome to Propel the Growth of Market at 6% CAGR through 2033: FMI Study	MARKITWIRED
23-Feb-2023	Growing Significance of Proactive Concept to Improve Patient Care Surging the Demand for Value-based Healthcare Services: Industry Predicted to Rise at 21.1% CAGR	MARKITWIRED
23-Feb-2023	Malaria Treatment Market to nearly reach US$ 3 Billion by 2033; expected to surge at a 5% CAGR \| FMI Report	MARKITWIRED
23-Feb-2023	iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer	iOmx Therapeutics AG
23-Feb-2023	Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board	Pan Cancer T
23-Feb-2023	Veterinary Rehabilitation Services Market Value to touch US$ 2.1 Billion by 2033; Companion Animals to account for 70% of all Facility Uses \| FMI	MARKITWIRED
23-Feb-2023	: Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023	Biophytis
23-Feb-2023	Rising Frequency of Chronic Diseases to Drive the Market for Arterial Cannula \| FMI Study	MARKITWIRED
23-Feb-2023	One in Five People in the World Suffers from the Horrendous Condition of Chronic Pain Size of Chronic Pain Market to Puff up US$ 142.53 Bn by 2033	MARKITWIRED
23-Feb-2023	Growing Incidence of Postoperative Pain and Emergence of Innovative Treatment Therapies to Drive Growth: Postoperative Pain Market to Surpass US$ 63 Billion By 2033	MARKITWIRED
23-Feb-2023	Nipah Virus (Niv) Infection Testing Market to Register 5.2% CAGR from 2023 to 2033 \| FMI Study	MARKITWIRED
23-Feb-2023	Rituximab to account for 40% of all Intraocular Lymphoma Treatments; Global Market Worth to surpass US$ 1 Billion by 2023-end \| FMI Report	MARKITWIRED
23-Feb-2023	Gerresheimer AG: Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels	Gerresheimer AG
23-Feb-2023	Combined Sales of Infertility Drugs Market Will Cross US$ 6,814.68 million by 2033; Ovulation Disorder is Leading to a Rise in Demand for Infertility Drugs	MARKITWIRED
23-Feb-2023	Laband Syndrome Therapeutics Market to reach US$ 5 Billion by 2033, expanding at a 5.2% CAGR \| Reports FMI	MARKITWIRED